Clinical trial
Exploring the Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease
NCT01711125 is registered in ClinicalTrials.gov with South West Sydney Local Health District as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease
- Lead sponsor
- South West Sydney Local Health District
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- June 30, 2017
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence, alcoholic liver disease